Pharmaceutical glass manufacturer Schott is to invest €76 million in Hungary to expand its production capacity.
The group said it was planning to expand its production facility at its Lukácsháza, Hungary facility to meet growing global demand for prefillable syringes (PFS) made of glass.
“The added capacity will greatly benefit the global market and strengthen supply security for major pharmaceutical companies and contract manufacturing organizations,” said Andreas Reisse, Executive Vice President of Schott’s Pharma business unit.
The investment is supported by the local government with about €9 million.
The expansion is scheduled for completion in 2024 and is designed to create 120 new jobs.
Schott’s Lukácsháza facility plays an important role in supplying the global industry with drug containment systems and provides enough space for further capacity expansions to follow.
Building on the strong existing foundation and skillset, the production will be equipped with modern machinery, it said.
As part of Schott's global production network in 13 countries, the manufacturing will follow high-end processes and advanced quality assurance.
